Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-02-01 Powala Christopher Chief Reg & Develop Officer Option exercise +3,400 142,843
2019-02-01 Powala Christopher Chief Reg & Develop Officer Shares withheld for taxes −1,114 $6.96 $8K 141,729
2019-02-01 Powala Christopher Chief Reg & Develop Officer Option exercise · Restricted Stock Units −3,400 10,200
2018-12-18 Powala Christopher Chief Reg & Develop Officer Option exercise +1,625 139,889
2018-12-18 Powala Christopher Chief Reg & Develop Officer Shares withheld for taxes −446 $6.30 $3K 139,443
2018-12-18 Powala Christopher Chief Reg & Develop Officer Option exercise · Restricted Stock Units −1,625 1,625
2018-12-15 Powala Christopher Chief Reg & Develop Officer Option exercise +1,300 138,621
2018-12-15 Powala Christopher Chief Reg & Develop Officer Shares withheld for taxes −357 $7.31 $3K 138,264
2018-12-15 Powala Christopher Chief Reg & Develop Officer Option exercise · Restricted Stock Units −1,300 2,600
2018-05-07 Powala Christopher Chief Reg & Develop Officer Option exercise +5,200 138,801
2018-05-07 Powala Christopher Chief Reg & Develop Officer Shares withheld for taxes −1,480 $18.10 $27K 137,321
2018-05-07 Powala Christopher Chief Reg & Develop Officer Option exercise · Restricted Stock Units −5,200 3,900
2018-02-01 Powala Christopher Chief Reg & Develop Officer Grant or award · Stock option (right to buy) +47,600 47,600
2018-02-01 Powala Christopher Chief Reg & Develop Officer Grant or award · Restricted stock units +13,600 13,600
2017-12-18 Powala Christopher Chief Operating Officer Option exercise +1,625 134,095
2017-12-18 Powala Christopher Chief Operating Officer Shares withheld for taxes −494 $24.12 $12K 133,601
2017-12-18 Powala Christopher Chief Operating Officer Option exercise · Restricted Stock Units −1,625 3,250
2017-12-15 Powala Christopher Chief Operating Officer Option exercise +1,300 132,865
2017-12-15 Powala Christopher Chief Operating Officer Shares withheld for taxes −395 $24.23 $10K 132,470
2017-12-15 Powala Christopher Chief Operating Officer Option exercise · Restricted Stock Units −1,300 9,100

Page 1 of 2 · 27 trades